ATOPIC DERMATITIS (ECZEMA)
Clinical trials for ATOPIC DERMATITIS (ECZEMA) explained in plain language.
Never miss a new study
Get alerted when new ATOPIC DERMATITIS (ECZEMA) trials appear
Sign up with your email to follow new studies for ATOPIC DERMATITIS (ECZEMA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could less medicine keep eczema under control? trial tests spacing out injections
Disease control Recruiting nowThis study is testing whether adults with atopic eczema (atopic dermatitis) that is already well-controlled can safely take their dupilumab medication less often. Researchers will randomly assign 216 participants to receive their standard injection every 2 weeks, or to try extend…
Matched conditions: ATOPIC DERMATITIS (ECZEMA)
Phase: PHASE4 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New pill tested to tame severe eczema itch and rash
Disease control Recruiting nowThis study is testing a new oral medication called soquelitinib for adults with moderate to severe eczema (atopic dermatitis). About 200 participants will take either the drug or a placebo pill daily for 12 weeks to see if it safely reduces skin inflammation and itching. Doctors …
Matched conditions: ATOPIC DERMATITIS (ECZEMA)
Phase: PHASE2 • Sponsor: Corvus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New drug trial offers hope for Tough-to-Treat eczema
Disease control Recruiting nowThis study is testing a new drug called IMG-007 to see if it can reduce the severity of eczema and is safe for adults with moderate-to-severe cases. It will compare different doses of the drug against a placebo (an inactive substance) in about 220 people over 52 weeks. The goal i…
Matched conditions: ATOPIC DERMATITIS (ECZEMA)
Phase: PHASE2 • Sponsor: Inmagene LLC • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC